Anne L. Rosen

Anne L. Rosen

Auto-generated profile, based on publicly available information

Anne L. Rosen

Department of Molecular Microbiology, Center or Women’s Infectious Disease Research, Washington University School of Medicine

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
Gaetano CiancioGaetano Ciancio
Gaetano Ciancio
GBGeorge William Burke
George William Burke
KSKiliana Suzart
Kiliana Suzart
AMAdela Mattiazzi
Adela Mattiazzi
AVAnil Vaidya
Anil Vaidya
JMJoshua Miller
Joshua Miller
Limited data are available on the use of tacrolimus and mycophenolate mofetil in conjunction with anti‐IL‐2 receptor antibody, in groups of kidney transplant recipients considered to be at higher ri...

16 February 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
GHGuy Hazan
Guy Hazan
AEAnna Eubanks
Anna Eubanks
CGCarrie Gierasch
Carrie Gierasch
JAJeffrey Atkinson
Jeffrey Atkinson
CFCarolyn Fox
Carolyn Fox
JHJeffrey A. Haspel
Jeffrey A. Haspel
Asthma is a chronic disease of childhood, but for unknown reasons, disease activity sometimes subsides as children mature. In this study, we present clinical and animal model evidence suggesting that the age dependency of childhood asthma stems from an evolving host response to respiratory viral infection. Using clinical data, we show that societal suppression of respiratory virus transmission during coronavirus disease 2019 lockdown disrupted the traditional age gradient in pediatric asthma exacerbations, connecting the phenomenon of asthma remission to virus exposure. In mice, we show that asthmatic lung pathology triggered by Sendai virus (SeV) or influenza A virus is highly age-sensitive: robust in juvenile mice (4–6 wk old) but attenuated in mature mice (>3 mo old). Interestingly, allergen induction of the same asthmatic traits was less dependent on chronological age than viruses. Age-specific responses to SeV included a juvenile bias toward type 2 airway inflammation that emerged early in infection, whereas mature mice exhibited a more restricted bronchiolar distribution of infection that produced a distinct type 2 low inflammatory cytokine profile. In the basal state, aging produced changes to lung leukocyte burden, including the number and transcriptional landscape of alveolar macrophages (AMs). Importantly, depleting AMs in mature mice restored post-SeV pathology to juvenile levels. Thus, aging influences chronic outcomes of respiratory viral infection through regulation of the AM compartment and type 2 inflammatory responses to viruses. Our data provide insight into how asthma remission might develop in children.

14 February 2024 in mBio
Verified
Journal Article
Open access
ARAnne L. Rosen
Anne L. Rosen
MLMichael A. Lint
Michael A. Lint
DVDayne H. Voelker
Dayne H. Voelker
NGNicole M. Gilbert
Nicole M. Gilbert
CTChristopher P. Tomera
Christopher P. Tomera
AKAndrew L. Kau
Andrew L. Kau
Annually, millions of people suffer from urinary tract infections (UTIs) and more than $3 billion are spent on work absences and treatment of these patients. While the early response to UTI is known to be important in combating urinary pathogens, knowledge of host factors that help curb infection is still limited. Here, we use a preclinical model of UTI to study secretory leukocyte protease inhibitor (SLPI), an antimicrobial protein, to determine how it protects the bladder against infection. We find that SLPI is increased during UTI, accelerates the clearance of bacteriuria, and upregulates genes and pathways needed to fight an infection while preventing prolonged bladder inflammation. In a small clinical study, we show SLPI is readily detectable in human urine and is associated with the presence of a uropathogen in patients without a previous history of UTI, suggesting SLPI may play an important role in protecting from bacterial cystitis.

3 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AHAriel J. Hernandez-Leyva
Ariel J. Hernandez-Leyva
ABAmalia Z. Berna
Amalia Z. Berna
YLYang Liu
Yang Liu
ARAnne L. Rosen
Anne L. Rosen
MLMichael A. Lint
Michael A. Lint
AKAndrew L. Kau
Andrew L. Kau
The gut microbiota is widely implicated in host health and disease, inspiring translational efforts to implement our growing body of knowledge in clinical settings. However, the need to characterize gut microbiota by its genomic content limits the feasibility of rapid, point-of-care diagnostics. The microbiota produces a diverse array of xenobiotic metabolites that disseminate into tissues, including volatile organic compounds (VOCs) that may be excreted in breath. We hypothesize that breath contains gut microbe-derived VOCs that inform the composition and metabolic state of the microbiota. To explore this idea, we compared the breath volatilome and fecal gut microbiomes of 27 healthy children and found that breath VOC composition is correlated with gut microbiomes. To experimentally interrogate this finding, we devised a method for capturing exhaled breath from gnotobiotic mice. Breath volatiles are then profiled by gas-chromatography mass-spectrometry (GC-MS). Using this novel methodology, we found that the murine breath profile is markedly shaped by the composition of the gut microbiota. We also find that VOCs produced by gut microbes in pure culture can be identified in vivo in the breath of mice monocolonized with the same bacteria. Altogether, our studies identify microbe-derived VOCs excreted in breath and support a mechanism by which gut bacterial metabolism directly contributes to the mammalian breath VOC profiles.

8 July 2026 in mBio
Verified
Journal Article
Open access
SLShuiqiao Liu
Shuiqiao Liu
ARAnne L. Rosen
Anne L. Rosen
BOBenjamin S. Olson
Benjamin S. Olson
YLYongke Lu
Yongke Lu
SHSuzanne Hickerson
Suzanne Hickerson
WXWei Xu
Wei Xu
Diabetes is associated with impaired immune function and increased susceptibility to severe bacterial infections, yet the pathogen-encoded mechanisms that exacerbate disease in this context remain poorly defined. Streptococcus pyogenes (group A Streptococcus [GAS]) causes invasive skin and soft tissue infections that are disproportionately severe in individuals with diabetes, often accompanied by delayed healing, excessive inflammation, and polymicrobial overgrowth. Here, we investigated how the GAS ClpX-dependent regulatory pathway (CDRP), a global virulence regulator, interacts with diabetic immune dysfunction to shape infection outcomes. Using two murine models of type I diabetes, we show that diabetic mice develop more severe and persistent GAS skin infections characterized by increased bacterial burden, exaggerated inflammatory responses, impaired neutrophil recruitment, excessive neutrophil extracellular trap (NET) accumulation, and frequent polymicrobial infections. Deletion of clpX significantly attenuated GAS virulence in both diabetic and non-diabetic hosts; however, the pathogenic consequences of CDRP were markedly amplified in the diabetic environment. In diabetic mice, CDRP promoted sustained inflammation, altered neutrophil behavior, impaired NET clearance, and enhanced tissue damage, leading to delayed resolution of infection. Mechanistically, ClpX-dependent virulence was associated with dysregulated protease-nuclease activity, excessive NET persistence, and defective neutrophil chemotaxis within diabetic lesions. Together, these findings indicate that while ClpX is a core regulator of GAS virulence, its downstream effects are disproportionately deleterious when host immune clearance is compromised. IMPORTANCE: Diabetic patients experience disproportionately severe bacterial infections, yet the microbial mechanisms that exacerbate disease in this immunocompromised context remain incompletely understood. This study demonstrates that the Streptococcus pyogenes ClpX-dependent regulatory pathway, a central regulator of virulence, amplifies tissue damage and inflammatory dysfunction during diabetic skin infection. ClpX-dependent regulation exacerbates disease by intensifying neutrophil dysregulation, excessive NET accumulation, and impaired resolution of infection in an already compromised host environment. These findings underscore the importance of host-pathogen interactions in shaping infection severity and suggest that targeting pathogen regulatory pathways may be particularly effective in settings of immune dysfunction such as diabetes.